CMR Surgical, based in Cambridge, has raised over $200 million in its latest funding round, bolstered by existing and new investors. The funds will primarily support international growth of the Versius Surgical Robotic System, particularly in the U.S., while also enhancing innovative product development, including the launch of the Versius Plus. Dan Moore, Non-Executive Chairman, emphasized this funding as a vote of confidence in CMR's leadership and its potential within the surgical robotics market, which aims to promote accessibility and efficiency in minimal access surgery.
CMR Surgical has secured over $200M in funding to advance its surgical robotic systems and expand its market presence, particularly in the U.S.
The funding will accelerate the commercial expansion of the Versius Surgical Robotic System globally, continuing innovation and product development.
Collection
[
|
...
]